Direx Group

What Direx Group does

Direx Group is an Israeli medical technology company founded in the 1980s that develops and manufactures non-invasive shockwave therapy systems used in urology, men's health, women's health, musculoskeletal, vascular, and aesthetic applications. The company's product portfolio spans two categories: the Morenova family of low-intensity shockwave therapy (LISWT) systems, which includes Tabletop, Pro, High Energy, and Home variants, and the high-energy Duet Magna, Integra, and Renova systems for kidney stone lithotripsy and erectile dysfunction treatment. Underlying technologies include proprietary Linear Shockwave Technology for full organ coverage, electromagnetic dual-shockwave architectures, and DICOM3/PACS imaging integration on the Integra lithotripter. The company emphasizes pain-free, drug-free treatment modalities and reports no adverse events across its clinical compendium.

The business operates as a hardware vendor, selling medical devices directly to hospitals, urology clinics, and multi-specialty healthcare providers through an enterprise field sales model, supplemented by a sub-dealer channel in China (Taiyuan-based distributor). Notable installed bases include Jianguo Traditional Chinese Medicine Hospital in Wuxi (43M+ shocks delivered since July 2020, 2,000+ patients treated), D Clinic Tokyo and Osaka in Japan, Royal Medical Center Abu Dhabi, and Dr. Cobi Reisman's clinic in Tel Aviv. The company operates through a closely related subsidiary, Initia Ltd., which handles commercial partnerships and is led by CEO Niv Ein-Gal. Pricing is quote-based and not publicly disclosed; no revenue, headcount, or funding figures are available. The company is privately held and self-describes 40+ years of continuous operation originating with one of the earliest lithotripters commercially available.

Name

Direx Group

Legal name

Direx Group

Website

https://direxgroup.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

51–100 employees

Short description

Direx Group is an Israeli medical device company that develops and sells non-invasive shockwave therapy systems for urology, men's health, women's health, musculoskeletal, vascular, and aesthetic applications to hospitals and clinics across more than six countries.

Ownership category

akta.pro rank

Product category

Shockwave Therapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Kidney Stone Management & Lithotripsy Devices (HLAHAKAI)

akta.pro secondary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Shockwave therapy devices
• Medical lithotripsy systems
• Low-intensity shockwave therapy
• Urology medical equipment
• Extracorporeal shockwave treatment

Headquarters

HQ city

Canton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Direx Group generates revenue through the sale of shockwave therapy medical devices including Morenova, Duet Magna, Integra, and Renova systems to healthcare providers, hospitals, and clinics worldwide.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Direx Group designs, develops, manufactures, and sells shockwave therapy medical devices to hospitals, clinics, and healthcare providers worldwide. The product portfolio spans the Morenova family of low-intensity shockwave therapy (LISWT) systems for men's health, women's health, musculoskeletal, vascular, kidney disease, esthetics, and alopecia indications, alongside high-energy lithotripsy systems (Duet Magna, Integra) for kidney stone treatment and Renova, the first dedicated shockwave system for erectile dysfunction using Linear Shockwave Therapy.

Product overview

Direx Group offers a comprehensive portfolio of shockwave therapy medical devices spanning both low-intensity (Morenova family) and high-energy (Duet Magna, Integra, Renova) systems. The Morenova family provides next-generation LISWT technology for diverse applications including women's health (urinary incontinence, sexual dysfunction), men's health (erectile dysfunction, Peyronie's disease, chronic prostatitis), vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders. The high-energy solutions include Duet Magna and Integra for kidney stone lithotripsy, and Renova as the first dedicated shockwave system for erectile dysfunction treatment using Linear Shockwave Therapy.

Differentiator

Problem solved

Functional benefit

Brands

• Morenova: Next generation low-intensity shockwave therapy (LISWT) technology platform offering treatment for various medical conditions including women's health, men's health, vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders
• Duet Magna
• Integra
• Renova

Products and services

• Morenova Family (LISWT Platform) Next-generation low-intensity shockwave therapy (LISWT) technology platform offering safe, affordable, and pain-free treatment solutions across women's health, men's health, vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders, sold to healthcare providers.
• Morenova Tabletop

Quantifiable outcome

• 43 million+ shockwaves delivered with consistent system performance over 4+ years of continuous operation
• +3 more outcomes

Named customers9 records

Segments8 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Six partnerships are on record, tiered core and major.

• Shanghai Taiyuan Life Science Ltd. (China)coreChannel Partner/ Reseller/ Distributor · 29 April 2025Strategic partnership for expanding shockwave therapy market in China. Nearly 10 years of collaboration, notably launching the Renova shockwave therapy system for erectile dysfunction in China with market-leading position. Focus areas include urology devices, ED therapy, orthopedic pain management, female sexual dysfunction, stress urinary incontinence, chronic wound healing, overactive bladder, and chronic kidney disease. Clinical trials expected to begin before end of 2025.
• Royal Medical Center Abu Dhabi (UAE)coreImplementation/ SI/ Consulting Partner · 10 March 20253-day on-site intensive training for Morenova Low Intensity Shockwave device. Multi-disciplinary exchange covering men's health (ED, PD, CPPS), women's health (SUI, FSD, OAB), orthopedics (MSDs), aesthetics (cellulite, stretch marks), and wound care (PAD). Live demonstrations and training conducted by product manager Jwana Akawe.
• Sapporo Medical University Hospital (Japan)majorStrategic or Co-development Partner · 3 December 2024Groundbreaking clinical study by Urological Department utilizing Renova treatment protocol. First-of-its-kind study investigating histological effects of Li-ESWT on corpus cavernosum. Renova employs Li-ESWT to promote angiogenesis and improve blood flow in the penis.
• D Clinic Tokyo and D Clinic Osaka (Japan)majorStrategic or Co-development Partner · 3 December 2024Two clinical trial sites for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) under guidance of Dr. Akira Tsujimura, Professor at Juntendo University Urayasu Hospital. Led by Dr. Taro Koyama (Tokyo) and Dr. Yoshihiro Yasuda (Osaka).
• Dr. Cobi Reisman (Israel/Netherlands)coreStrategic or Co-development Partner · 5 August 2024Collaboration with renowned urology and sexual health expert, founder of European Training and Certification Program in Sexual Health and Sexual Therapy, former President of European Society for Sexual Health (ESSM). Dr. Reisman brings expertise to MoreNova at his clinic in Tel Aviv-Yafo, treating ED, chronic pelvic pain, Peyronie's disease, and women's health conditions.
• Jianguo Traditional Chinese Medicine Hospital (Wuxi, China)majorOthersPrivate hospital specializing in andrology that has operated Renova system since July 2020, achieving 43 million+ shockwaves delivered and treating over 2,000 patients. System supplied through sub-dealer in Taiyuan.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Boston Scientific: Large diversified medical device company offering urology products including stone management solutions (lithotripsy, ureteroscopy). While not focus-built shockwave specialist, Boston Scientific competes for hospital urology budgets and may expand into LISWT indications.
• Chattanooga (DJO): DJO Global's Chattanooga division offers physical therapy and rehabilitation equipment including shockwave therapy devices. Competes with Direx's Morenova platform in musculoskeletal and orthopedic applications within rehabilitation medicine.
• EDAP TMS: French medical device company specializing in therapeutic ultrasound and urology, including high-intensity focused ultrasound (HIFU) for prostate conditions and lithotripsy systems. Overlaps with Direx's urology-focused product lines.
• Karl Storz: German endoscopy and surgical device manufacturer with significant urology presence, including ureteroscopy and related stone management products. Competes with Direx indirectly in urology, where endoscopy competes with ESWL for certain kidney stone cases.

Direct peers

• BTL Industries: Czech-based manufacturer of shockwave therapy devices (focused, radial, and planar) for aesthetic, physiotherapy, andrology, and orthopedics applications. Competes directly with the Morenova platform across ED, women's health, and musculoskeletal indications.
• Zimmer MedizinSysteme: German medical device company offering focused and radial shockwave therapy systems primarily for orthopedic, sports medicine, and aesthetic applications. Direct competitor to Direx's Morenova systems in musculoskeletal and general shockwave therapy markets.
• Dornier MedTech: German-headquartered medical device company specializing in lithotripsy systems for urology, including ESWL and laser-based stone management. Direct competitor to Direx's Duet Magna and Integra ESWL product families, particularly in hospital urology departments.
• Storz Medical: Swiss-based pioneer in shockwave therapy and lithotripsy systems, offering both ESWL for kidney stones and focused/diffuse/radial shockwave therapy for orthopedic and aesthetic applications. Directly competes with Direx across both lithotripsy (Duet Magna, Integra) and LISWT (Morenova) product lines.
• Gymna: Belgian manufacturer of medical devices including shockwave therapy systems (radial shockwave) for physiotherapy, orthopedics, and aesthetic applications. Direct competitor in the broader shockwave therapy market Direx addresses with Morenova systems.
• Richard Wolf: German manufacturer of urology and endoscopy equipment, including ESWL systems. Overlaps with Direx's Duet Magna and Integra lithotripsy offerings, particularly in hospitals and urology centers requiring integrated stone management solutions.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/direx-healthcare
• Xx.com/direxgroup1
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Direx Group